Chartloom is one Koyfin alternative for visual stock research on US equities, with AI SEC summaries, Scenario Lab (bull, base, and bear cases), and 100+ financial charts. Koyfin may suit data-focused investors who prioritise advanced charting, screening, and institutional-grade financial visualisations.
A short read on who each platform is built for.
Chartloom may suit
Investors who want AI-powered analysis, scenario modelling, and an all-in-one research dashboard.
Koyfin may suit
Data-focused investors who prioritise advanced charting, screening, and institutional-grade financial visualisations.
Search a ticker to open fundamental charts, valuation metrics, and a free AI report. Compare the workflow against Koyfin using the table above.
Start for Free · Create a free account or log in
Public list prices. They can change.
Prices last checked on 2026-02-07. Confirm on each pricing page.
Chartloom offers 70+ US fundamental screener filters plus AI SEC summaries and Scenario Lab. Koyfin's institutional-grade screening serves investors who need broader multi-asset, multi-factor filtering.
Chartloom includes AI SEC filing summaries and a Scenario Lab for testing investment theses. Koyfin does not offer AI SEC summaries or a Scenario Lab; it emphasises advanced charting and screening. Both offer customisable dashboards and extensive charting; the difference is in the presence of AI-driven filing analysis and scenario modelling.
Both platforms offer substantial charting. Chartloom provides over 100 interactive charts and 70+ US fundamental screener filters. Koyfin offers institutional-grade, multi-asset screening and filtering. Investors who prioritise that broader screening workflow may find Koyfin aligned; those who prioritise SEC summaries and scenario testing may look to Chartloom.
Chartloom offers a Free plan; Pro is $10/month. Koyfin Plus is listed at $49/month. Pricing is taken from each platform's public pricing page and may change.
Both platforms offer extensive financial charting. Chartloom includes 100+ interactive charts with AI-powered analysis and scenario modelling. Koyfin focuses on advanced charting with institutional-grade visualisations and screening tools.
Koyfin does not currently offer AI-generated SEC filing summaries. Chartloom provides AI summaries of 10-K and 10-Q filings to help investors quickly understand business models and risk factors.
Based on publicly listed pricing, Chartloom offers a Free plan; Pro is $10/month while Koyfin Plus is $49/month. Pricing may change - refer to each platform for current rates.
Investors comparing sites like Koyfin often evaluate market coverage, source transparency, pricing, chart depth, portfolio tools, and whether the workflow is data-led or content-led. Chartloom is one option for US-equity research with AI SEC summaries, Scenario Lab, 100+ charts, and a Free plan; Koyfin may still fit data-focused investors who prioritise advanced charting, screening, and institutional-grade financial visualisations.
Based on publicly listed pricing as of 2026-02-07, Chartloom offers a Free plan and Pro at $10/month. Koyfin is listed as $49/mo (Plus) (Plus (monthly billing)). Published rates may change; confirm on each platform's pricing page.
Chartloom Scenario Lab supports bull, base, and bear cases for stress-testing a thesis against company financials. The feature table on this page shows whether the other platform lists a similar workflow.
Chartloom is built for visual fundamental research on US stocks. It includes 100+ interactive financial charts, AI SEC filing summaries, and Scenario Lab bull, base, and bear modelling.